Clarivate Plc [NYSE: CLVT] has shared a new report which analyzes the research performance of each of the member countries of the G20 with a visual comparative snapshot for each nation. It also features a special analysis of the G20 members’ COVID-19 research as indexed in the Web of Science research publication and citation index.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The report titled “The Annual G20 Scorecard: Research Performance 2021” has been designed by the Institute for Scientific Information at Clarivate before this year’s G20 Summit, which will be organized virtually by Rome, Italy on October 30-31. The report features both a written summary and an array of graphs and exhibits that emphasize the research performance of G20 countries.
Furthermore, the report emphasizes the different national responses to COVID-19 and the link to each region’s research investment and subject diversity. It discovers that regions with more even research bases, especially the US, Germany, and the UK, tend to back a response across a broader range of COVID-19 topics.
Additionally, the G20 is a group of 19 leading economies, with the EU as the additional 20th member. The report discovered that in the US, although investment is increasing, output has plateaued, and output/researcher has dropped below the G20 average. It also disclosed that in Italy, productivity per GERD is well beyond the G20 average.
